3rd Quarter - Report
SIDLEY AUSTIN LLP for PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Firm
Income
$30,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 15, 2009 | $30,000 | Replaced |
| 3rd Quarter - Report | Oct 30, 2009 | $30,000 | Replaced |
| 3rd Quarter - Amendment | Oct 30, 2009 | $30,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Health care reform, H.R. 3200
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN P FORD New | Sr. Counsel, House Energy & Commerce |
Trade (domestic/foreign) TRD
WTO enforcement actions on intellectual property; pharmaceutical industry issues pertinent in WTO and FTA negotiations and implementation
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFREY P KUSHAN | N/A |
| JON P SANTAMAURO New | N/A |
| ANDREW W SHOYER | N/A |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.